Related Experiment Video

Updated: Jun 19, 2026

A Simple and Rapid Method for Simultaneous Isolation of Primary Islets and Primary Pancreatic Acinar Cells from Mice
14:39

A Simple and Rapid Method for Simultaneous Isolation of Primary Islets and Primary Pancreatic Acinar Cells from Mice

Published on: January 9, 2026

Overcoming self-destruction in the pancreas

Jennifer Nichols1, Anne Cooke

  • 1Wellcome Trust Centre for Stem Cell Research, Tennis Court Rd, Cambridge CB2 1QR, United Kingdom. jn270@cam.ac.uk

Current Opinion in Biotechnology
|October 28, 2009
PubMed

Insights

Type 1 diabetes destroys insulin-producing cells. Research explores halting this autoimmune destruction and recovering beta cells through new therapeutic pathways and stem cell differentiation for future treatments.

Area of Science:

  • Immunology
  • Endocrinology
  • Regenerative Medicine

Background:

  • Type 1 diabetes (T1D) is an autoimmune condition characterized by the progressive destruction of insulin-producing pancreatic beta cells.
  • Current management relies on exogenous insulin, as a cure is unavailable.
  • Existing therapeutic avenues include immune tolerance strategies and islet transplantation, though cell availability limits widespread application.

Purpose of the Study:

  • To explore novel tolerogenic strategies for halting autoimmune destruction and promoting beta cell recovery in Type 1 diabetes.
  • To identify specific polygenic pathways for targeted drug discovery and therapeutic intervention.
  • To investigate the utility of stem cell differentiation protocols for generating pancreatic tissue and understand T1D pathogenesis using a mouse model.

Main Methods:

  • Review of current research on Type 1 diabetes pathogenesis and therapeutic strategies.
  • Analysis of polygenic control in T1D to identify candidate pathways.
  • Examination of stem cell differentiation protocols for pancreatic tissue generation.
  • Utilizing embryonic stem cells from a Type 1 diabetes mouse model.

Main Results:

  • Tolerogenic strategies and stem cell differentiation show promise for Type 1 diabetes treatment.
  • Identification of specific genetic pathways could enhance drug discovery for T1D.
  • Stem cells from T1D models offer a tool to study disease mechanisms.

Conclusions:

  • Targeting specific pathways and utilizing stem cell-based therapies are key future directions for Type 1 diabetes treatment.
  • Further research into the genetic underpinnings and regenerative potential is crucial for developing effective therapies.
  • Stem cell research provides valuable insights into the causes and progression of Type 1 diabetes.

More Related Videos

A Simple High Efficiency Protocol for Pancreatic Islet Isolation from Mice06:56

A Simple High Efficiency Protocol for Pancreatic Islet Isolation from Mice

Published on: August 30, 2019

An Obstructive Chronic Pancreatitis Model Established Through Electrocoagulation06:28

An Obstructive Chronic Pancreatitis Model Established Through Electrocoagulation

Published on: October 31, 2025

Related Concept Videos

Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Chronic Pancreatitis I: Introduction01:25

Chronic Pancreatitis I: Introduction

Chronic pancreatitis is a long-standing, relapsing inflammation of the pancreas, characterized by irreversible damage to the gland. It results in progressive destruction of the pancreatic parenchyma, fibrosis, and eventual loss of both exocrine and endocrine function. The disease may evolve gradually after multiple episodes of acute pancreatitis or develop independently.EtiologyChronic pancreatitis can arise from a variety of causes:Alcohol use is the leading cause, accounting for 70–80% of...
Chronic Pancreatitis I: Introduction01:24

Chronic Pancreatitis I: Introduction

The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Chronic Pancreatitis II: Pathophysiology01:21

Chronic Pancreatitis II: Pathophysiology

Chronic pancreatitis is a progressive and irreversible inflammation of the pancreas, most often caused by long-term alcohol abuse, but it can also be related to ductal obstruction, smoking, or genetic factors.Chronic pancreatitis occurs when the pancreas is repeatedly exposed to harmful agents like alcohol, smoking, ductal obstruction, or genetic predisposition. These factors lead to the release of toxic metabolites and inflammatory cytokines, sustaining chronic inflammation in the pancreatic...
Acute Pancreatitis II: Clinical Manifestations and Management01:30

Acute Pancreatitis II: Clinical Manifestations and Management

Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
Acute Pancreatitis II: Pathophysiology01:21

Acute Pancreatitis II: Pathophysiology

The pathophysiology of acute pancreatitis centers on injury to pancreatic acinar cells, which initiates a cascade of harmful intracellular events.This injury leads to premature activation of trypsinogen to trypsin in the pancreas. Trypsin then activates other digestive enzymes, such as chymotrypsin, elastase, and phospholipase A2, which begin breaking down pancreatic tissue. The resulting autodigestion causes local inflammation, tissue swelling, hemorrhage, and fat necrosis.Injured acinar cells...